Toronto Dominion Bank
INDV icon

Toronto Dominion Bank’s Indivior Pharmaceuticals INDV Stock Holding History

Toronto Dominion Bank’s Portfolio INDV Stock Details INDV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$624K Buy
+20,484
New +$676K ﹤0.01% 1395
2024
Q3 		– Sell
-1,141,377
Closed -$18.4M – 1297
2024
Q2 		$18.4M Sell
1,141,377
-953,488
-46% -$17.2M 0.03% 333
2024
Q1 		$44.9M Buy
2,094,865
+769,000
+58% +$14.4M 0.07% 183
2023
Q4 		$20.2M Hold
1,325,865
– – 0.03% 370
2023
Q3 		$30.6M Hold
1,325,865
– – 0.05% 264
2023
Q2 		$30.7M Buy
+1,325,865
New +$30.4M 0.05% 275

Other funds holding INDV

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
OCM
Oaktree Capital Management Los Angeles, California $6.56B AUM 42.97% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
TSC
Two Seas Capital Rye, New York $7.15B AUM 169.27% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management San Mateo, California $29.7B AUM 43.33% 1-Year Est. Return
MAP
Madison Avenue Partners New York $2.3B AUM 115.82% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Toronto Dominion Bank's INDV Position: Q1 2026 in Review

Toronto Dominion Bank opened a new position in Indivior Pharmaceuticals (INDV) in Q1 2026: 20,484 shares worth $624K. The stake represents ﹤0.01% of the portfolio and ranks #1395 among its holdings. This is a return to the name: Toronto Dominion Bank previously reported a position in INDV as recently as Q2 2024.

Toronto Dominion Bank first reported a position in INDV in Q2 2023 and has held it in 6 quarters since. The position peaked at $44.9M in Q1 2024. 289 funds tracked by Wall St. Rank hold INDV as of Q1 2026.

  • Toronto Dominion Bank held 20,484 shares of Indivior Pharmaceuticals worth $624K as of Q1 2026.
  • Indivior Pharmaceuticals was a new Toronto Dominion Bank position in Q1 2026.
  • Indivior Pharmaceuticals made up ﹤0.01% of Toronto Dominion Bank's portfolio in Q1 2026, its #1395 holding.
  • Toronto Dominion Bank first reported a position in Indivior Pharmaceuticals in Q2 2023 and has held it in 6 quarters since.
  • Toronto Dominion Bank's Indivior Pharmaceuticals position peaked at $44.9M in Q1 2024.
  • 289 funds tracked by Wall St. Rank held Indivior Pharmaceuticals as of Q1 2026.

Based on Toronto Dominion Bank's 13F filing for Q1 2026, filed 15 May 2026.